Dermisonics, Inc.
DMSI - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.92K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1,917.00 |
|---|---|
| Enterprise Value | $2.63 Million |
| Earnings per Share | $-0.12 |
| Beta | -4.23 |
| Outstanding Shares | 60,180,194 |
Return
| Return on Equity | 537.80% |
|---|---|
| Return on Assets | -64094.80% |
| Return on Invested Capital | 131.42% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.03 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.01 |
| Debt to Equity | -0.63 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Dermisonics, Inc.
0CEO: Bruce H. Haglund
Dermisonics, Inc. develops and produces ultrasonic technologies and equipment for the transdermal administration of medications. A core focus for the company is the creation, evaluation, and market launch of its unique active transdermal...